Chen Liang, Wang Xin, Liu Youping, Di Xin
School of Pharmacy, Shenyang Pharmaceutical University,103 Wenhua Road, Shenyang 110016, PR China.
School of Pharmacy, Shenyang Pharmaceutical University,103 Wenhua Road, Shenyang 110016, PR China.
J Pharm Biomed Anal. 2017 Sep 5;143:269-276. doi: 10.1016/j.jpba.2017.06.001. Epub 2017 Jun 2.
A novel strategy was developed for dual-target screening of bioactive components from traditional Chinese medicines (TCMs). This strategy was based on the use of low-cost microporous hollow fibers filled with target enzymes as baits to "fish out" the ligands in TCM extracts, followed by identification of the ligands dissociated from the target-ligand complexes by liquid chromatography-mass spectrometry. Ganjiang Huangqin Huanglian Renshen Decoction (GHHRD), a classical TCM prescription for diabetes treatment, was chosen as a model sample to evaluate the feasibility of the proposed strategy. Three bioactive components were successfully screened out from GHHRD. Coptisine was identified as the ligand of α-glucosidase and baicalin as the ligand of angiotensin-converting enzyme (ACE). Berberine was found to be a dual inhibitor of α-glucosidase and ACE. The results were further verified by enzyme inhibitory assay and molecular docking simulation. The study suggested that our developed strategy would be a powerful tool for screening bioactive components from multi-component and multi-target TCMs.
开发了一种用于从中药中双重靶向筛选生物活性成分的新策略。该策略基于使用填充有靶酶的低成本微孔中空纤维作为诱饵,从中药提取物中“钓出”配体,然后通过液相色谱-质谱法鉴定从靶-配体复合物中解离的配体。选择用于治疗糖尿病的经典中药方剂干姜黄芩黄连人参汤(GHHRD)作为模型样品,以评估所提出策略的可行性。从GHHRD中成功筛选出三种生物活性成分。黄连碱被鉴定为α-葡萄糖苷酶的配体,黄芩苷被鉴定为血管紧张素转换酶(ACE)的配体。发现小檗碱是α-葡萄糖苷酶和ACE的双重抑制剂。通过酶抑制试验和分子对接模拟进一步验证了结果。该研究表明,我们开发的策略将成为从多成分、多靶点中药中筛选生物活性成分的有力工具。